EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrated homeopathy with standardized levothyroxine therapy for hypothyroidism: A double-blind, randomized, placebo-controlled trial in children and adults

Himani Jain, Sakhawat Hossain, Arpita Basu, Soumya Bhattacharyya, Saima Shamim, Pintu Debnath, Snigdha Chhaya Halder, Surbhi Yaduvanshi, Priyanka Sen, Munmun Koley, Subhranil Saha

Medicine Research and Clinical Practice · 2026-04 · 3 (2) · 27-36

DOI: 10.4103/mrcp.mrcp_10_26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicine Research and Clinical Practice, online erschienen am 25.06.2026. Verfasst von Himani Jain und 10 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypothyroidism is a prevalent hormonal disorder symptoms often persist despite levothyroxine therapy. Adjunctive individualized homeopathic medicines (IHMs) may improve clinical outcomes, biochemical markers, and quality of life, robust evidence of efficacy remains limited.

Objective

The objective of the study was to evaluate the efficacy of add-on IHMs alongside standard levothyroxine therapy in the treatment of hypothyroidism in children and adults.

Methods

A 3-month, double-blind, randomized, placebo-controlled trial was conducted in a homeopathic hospital involving 64 trial subjects with hypothyroidism undergoing levothyroxine therapy. The participants received either IHMs plus levothyroxine (verum; n = 32) or placebo plus levothyroxine (control; n = 32) for 3 consecutive months. The primary outcome was the Zulewski’s Clinical Scoring (ZCS); secondary outcomes included thyroid-stimulating hormone (TSH), T3, T4, and ThyroPRO-39 scores.

Results

Both groups showed significant improvement in symptoms and thyroid indices. Between-group difference in ZCS was nonsignificant (mean diff: 0.1, 95% confidence interval [CI] −0.3–0.6, P = 0.567), but significant in T3 (mean diff: −0.2, 95% CI − 0.4 to − 0.1, P = 0.002), T4 (mean diff: 1.6, 95% CI 1.2–2.0, P < 0.001), and TSH (mean diff: −3.0, 95% CI − 5.8 to − 0.3, P = 0.033), favoring homeopathy against placebo. Quality-of-life changes were minimal, though some ThyroPRO-39 domains improved significantly with IHMs (e.g., symptoms, P < 0.001; tiredness, P = 0.012; nervousness and tension, P = 0.001; and daily activity, P = 0.001).

Conclusion

Adjunctive IHMs did not improve symptoms or quality-of-life outcomes over placebo conclusively, but revealed favorable biochemical changes, meriting further long-term studies. Trial Registration: CTRI/2023/04/051311

Zitieren

APA

Jain, H., Hossain, S., Basu, A., Bhattacharyya, S., Shamim, S., Debnath, P., Halder, S. C., Yaduvanshi, S., Sen, P., Koley, M., & Saha, S. (2026). Integrated homeopathy with standardized levothyroxine therapy for hypothyroidism: A double-blind, randomized, placebo-controlled trial in children and adults. Medicine Research and Clinical Practice, 3(2), 27-36. https://doi.org/10.4103/mrcp.mrcp_10_26

Vancouver

Jain H, Hossain S, Basu A, Bhattacharyya S, Shamim S, Debnath P, et al. Integrated homeopathy with standardized levothyroxine therapy for hypothyroidism: A double-blind, randomized, placebo-controlled trial in children and adults. Medicine Research and Clinical Practice. 2026;3(2):27-36. doi:10.4103/mrcp.mrcp_10_26

BibTeX
@article{Jain2026,
  author = {Jain, Himani and Hossain, Sakhawat and Basu, Arpita and Bhattacharyya, Soumya and Shamim, Saima and Debnath, Pintu and Halder, Snigdha Chhaya and Yaduvanshi, Surbhi and Sen, Priyanka and Koley, Munmun and Saha, Subhranil},
  title = {Integrated homeopathy with standardized levothyroxine therapy for hypothyroidism: A double-blind, randomized, placebo-controlled trial in children and adults},
  journal = {Medicine Research and Clinical Practice},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {27--36},
  doi = {10.4103/mrcp.mrcp_10_26}
}
Kostenlos starten →